TECX Tectonic Therapeutic, Inc.

Nasdaq tectonictx.com


$ 17.39 $ -0.74 (-4.05 %)    

Monday, 03-Nov-2025 16:20:09 EST
QQQ $ 629.62 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.69 $ -2.29 (-0.33 %)
TLT $ 89.69 $ 0.07 (0.08 %)
GLD $ 366.10 $ 0.05 (0.01 %)
$ 17.51
$ 18.24
$ 17.17 x 15
$ 17.51 x 5
$ 16.59 - $ 18.51
$ 13.70 - $ 61.07
598,742
na
327.65M
$ 1.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-20-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-14-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-17-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-18-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 03-25-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Oppenheimer analyst Leland Gershell initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and an...

Core News & Articles

Truist Securities analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and anno...

Core News & Articles

-SEC Filing

Core News & Articles

Raymond James analyst Michael Freeman reinstates Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and announces $76 pric...

Core News & Articles

Data confirmed TX45's tolerability profile and improvements in left ventricular function and pulmonary hemodynamics in pati...

Core News & Articles

Mizuho analyst Uy Ear maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and raises the price target from $51 to...

Core News & Articles

Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION